Skip to main content

Advertisement

Table 3 Comorbidity in soft tissue sarcoma patients (N = 1246) and the general comparison cohort (N = 6230) before diagnosis/index date according to the Charlson Comorbidity Index

From: Relative mortality in soft tissue sarcoma patients: a Danish population-based cohort study

Condition STS patients N (%) General population cohort N (%) P-value
Myocardial infarct 44 (3.5) 188 (3.0) 0.34
Congestive heart failure 22 (1.8) 133 (1.8) 0.91
Peripheral vascular disease 27 (2.2) 100 (1.6) 0.16
Cerebrovascular disease 44 (3.5) 259 (4.2) 0.31
Dementia 5 (0.4) 39 (0.6) 0.34
Chronic pulmonary disease 47 (3.8) 259 (4.2) 0.53
Connective tissue disease 18 (1.4) 97 (1.6) 0.77
Ulcer disease 37 (3.0) 167 (2.7) 0.57
Mild liver disease 7 (0.6) 31 (0.5) 0.77
Diabetes 33 (2.7) 164 (2.6) 0.97
Hemiplegia 1 (0.1) 4 (0.1) 0.84
Moderate/severe renal disease 11 (0.9) 39 (0.6) 0.31
Diabetes with end organ damage 7 (0.6) 67 (1.1) 0.10
Any tumour* 121 (9.7) 323 (5.2) <0.001
Leukemia 4 (0.3) 9 (0.1) 0.17
Lymphoma 5 (0.4) 14 (0.2) 0.26
Moderate/severe liver disease 0 (0.0) 6 (0.1) 0.27
Metastatic solid tumour 32 (2.6) 22 (0.4) <0.001
AIDS 0 (0.0) 3 (0.1) 0.44
  1. NOTES: Abbreviations: STS soft tissue sarcoma, AIDS acquired immunedeficiency syndrome. Chi-squared test. *Excluding tumour in soft tissue and bone (ICD-8; 170, 171, 192.49-99 and ICD-10; C40-C41, C47, C49).